Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2248)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$520.34
Total Value
$20.81K
Shares Held After
49,973
% of Holdings
0.1%
Nutex Health Inc. (NUTX)
Jaumot Frank E — Director
Shares
150
Price
$93.56
Total Value
$14.03K
Shares Held After
150
% of Holdings
100.0%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
169,472
Price
$1.41
Total Value
$238.96K
Shares Held After
8,743,276
% of Holdings
1.9%
Airsculpt Technologies, Inc. (AIRS)
Chernett Jorey — 10% Owner
Shares
40,000
Price
$2.77
Total Value
$110.80K
Shares Held After
6,793,761
% of Holdings
0.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
280
Price
$200.90
Total Value
$56.25K
Shares Held After
21,032
% of Holdings
1.3%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
235
Price
$199.88
Total Value
$46.97K
Shares Held After
21,312
% of Holdings
1.1%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
235
Price
$198.49
Total Value
$46.64K
Shares Held After
21,547
% of Holdings
1.1%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
371
Price
$200.97
Total Value
$74.56K
Shares Held After
21,032
% of Holdings
1.7%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
140
Price
$199.82
Total Value
$27.98K
Shares Held After
21,403
% of Holdings
0.6%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
239
Price
$198.85
Total Value
$47.53K
Shares Held After
21,543
% of Holdings
1.1%
Evolus, Inc. (EOLS)
Avelar Rui — See Remarks
Shares
3,119
Price
$4.75
Total Value
$14.82K
Shares Held After
427,423
% of Holdings
0.7%
Evolus, Inc. (EOLS)
MOATAZEDI DAVID — Director
Shares
13,669
Price
$4.75
Total Value
$64.93K
Shares Held After
604,700
% of Holdings
2.2%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
5,044
Price
$50.02
Total Value
$252.29K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
3,795
Price
$49.32
Total Value
$187.17K
Shares Held After
5,044
% of Holdings
42.9%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
6,161
Price
$48.20
Total Value
$296.98K
Shares Held After
8,839
% of Holdings
41.1%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
1,200
Price
$79.94
Total Value
$95.93K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
600
Price
$79.24
Total Value
$47.55K
Shares Held After
1,200
% of Holdings
33.3%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
700
Price
$77.71
Total Value
$54.40K
Shares Held After
1,800
% of Holdings
28.0%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
1,596
Price
$18.95
Total Value
$30.25K
Shares Held After
339,392
% of Holdings
0.5%
VIEMED HEALTHCARE, INC. (VMD)
Moore Michael — President
Shares
65,000
Price
$8.77
Total Value
$570.05K
Shares Held After
1,585,812
% of Holdings
3.9%
OPKO HEALTH, INC. (OPK)
PAGANELLI JOHN A — Director
Shares
10,000
Price
$1.14
Total Value
$11.35K
Shares Held After
394,340
% of Holdings
2.5%
Neuronetics, Inc. (STIM)
Sullivan Keith J — Former Officer & Director
Shares
46,289
Price
$1.34
Total Value
$62.03K
Shares Held After
1,590,924
% of Holdings
2.8%
Neuronetics, Inc. (STIM)
Pfanstiel Steven — EVP, CFO and Treasurer
Shares
16,431
Price
$1.34
Total Value
$22.02K
Shares Held After
828,781
% of Holdings
1.9%
Neuronetics, Inc. (STIM)
MACAN WILLIAM ANDREW — EVP, CLO and CS
Shares
16,005
Price
$1.34
Total Value
$21.45K
Shares Held After
897,270
% of Holdings
1.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.18
Total Value
$251.21K
Shares Held After
490,582
% of Holdings
3.7%
IONIS PHARMACEUTICALS INC (IONS)
Schneider Eugene — EVP, Chf Clinical Develop Ofcr
Shares
5,812
Price
$70.97
Total Value
$412.49K
Shares Held After
63,890
% of Holdings
8.3%
AdaptHealth Corp. (AHCO)
CASHIN RICHARD M JR — 10% Owner
Shares
727
Price
$9.94
Total Value
$7.23K
Shares Held After
15,865,598
% of Holdings
0.0%
Heartflow, Inc. (HTFL)
Rogers Campbell — Chief Medical Officer
Shares
64,533
Price
$25.69
Total Value
$1.66M
Shares Held After
78,518
% of Holdings
45.1%
ALX ONCOLOGY HOLDINGS INC (ALXO)
Pinto Shelly — SVP, FINANCE AND CAO
Shares
903
Price
$2.17
Total Value
$1.96K
Shares Held After
86,805
% of Holdings
1.0%
ALX ONCOLOGY HOLDINGS INC (ALXO)
Lettmann Jason — Director
Shares
12,311
Price
$2.17
Total Value
$26.71K
Shares Held After
293,609
% of Holdings
4.0%
RadNet, Inc. (RDNT)
Sorensen Alma Gregory — Director
Shares
100
Price
$63.59
Total Value
$6.36K
Shares Held After
1,208,923
% of Holdings
0.0%
RadNet, Inc. (RDNT)
Sorensen Alma Gregory — Director
Shares
5,346
Price
$62.82
Total Value
$335.84K
Shares Held After
1,209,023
% of Holdings
0.4%
RadNet, Inc. (RDNT)
Sorensen Alma Gregory — Director
Shares
9,554
Price
$61.84
Total Value
$590.82K
Shares Held After
1,214,369
% of Holdings
0.8%
Nutex Health Inc. (NUTX)
Hosseinion Warren — Director
Shares
252
Price
$94.07
Total Value
$23.71K
Shares Held After
7,765
% of Holdings
3.2%
iBio, Inc. (IBIO)
Duran Felipe — Chief Financial Officer
Shares
24,835
Price
$2.02
Total Value
$50.13K
Shares Held After
35,974
% of Holdings
69.0%
iBio, Inc. (IBIO)
Brenner Martin — Director
Shares
12,336
Price
$2.02
Total Value
$24.92K
Shares Held After
30,652
% of Holdings
40.2%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
6,905
Price
$18.78
Total Value
$129.70K
Shares Held After
339,392
% of Holdings
2.0%
VIEMED HEALTHCARE, INC. (VMD)
Moore Michael — President
Shares
40,232
Price
$9.21
Total Value
$370.54K
Shares Held After
1,650,812
% of Holdings
2.4%
Aldeyra Therapeutics, Inc. (ALDX)
DOUGLAS RICHARD — Director
Shares
70,000
Price
$1.40
Total Value
$98.00K
Shares Held After
195,000
% of Holdings
35.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$532.90
Total Value
$21.32K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$531.90
Total Value
$127.66K
Shares Held After
40,553
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,431
Price
$531.20
Total Value
$760.15K
Shares Held After
40,793
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,608
Price
$530.20
Total Value
$852.56K
Shares Held After
42,224
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,950
Price
$529.32
Total Value
$1.03M
Shares Held After
43,832
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,241
Price
$528.31
Total Value
$655.63K
Shares Held After
45,782
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,515
Price
$527.30
Total Value
$798.86K
Shares Held After
47,023
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
876
Price
$526.27
Total Value
$461.01K
Shares Held After
48,538
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
599
Price
$525.08
Total Value
$314.52K
Shares Held After
49,414
% of Holdings
1.2%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
608
Price
$4.78
Total Value
$2.91K
Shares Held After
537,116
% of Holdings
0.1%
SOPHiA GENETICS SA (SOPH)
CARDOZA GEORGE — Chief Financial Officer
Shares
774
Price
$4.79
Total Value
$3.70K
Shares Held After
184,858
% of Holdings
0.4%
Showing 401–450 of 2248 transactions (page 9 of 45)